News Headlines Article

FTC Seeks More Information on Pfizer-Allergan Merger
The Wall Street Journal

Pfizer Inc. and Allergan PLC on Wednesday said federal regulators are seeking more information on their pending merger deal, a so-called inversion that would create the world’s biggest drugmaker and move one of the top names in corporate America to a foreign country.

The request from the Federal Trade Commission was “fully anticipated as part of the regulatory process,” the companies said. They still expect the deal to close in the second of this year.

Commands